XML 65 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Fair Value Measurement (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended 24 Months Ended
Nov. 30, 2020
Sep. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2023
Assets and liabilities measured at fair value            
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Other Nonoperating Income (Expense)
Estimated fair value of long-term debt     $ 416,900     $ 416,900
Estimated fair value of marketable securities     134,000     134,000
Payments of contingent consideration     7,024      
MedCerts            
Assets and liabilities measured at fair value            
Ownership percentage acquired (as a percent) 100.00%          
Total consideration $ 70,000          
Contingent consideration $ 10,800          
Expense on estimate of fair value of contingent consideration           500
Fair value of the contingent consideration     11,300     11,300
Payments of contingent consideration   $ 7,000        
MedCerts | Selling, General, and Administrative Expenses            
Assets and liabilities measured at fair value            
Gain on contingent consideration   4,300        
Measured on a recurring basis | Contingent Consideration | Acquisitions            
Assets and liabilities measured at fair value            
Fair Value Liability, beginning of period   11,290 11,290      
Fair Value Liability, ending of period       $ 11,290    
Measured on a recurring basis | Convertible Note | Acquisitions            
Assets and liabilities measured at fair value            
Fair Value Asset, beginning of period   889 889      
Fair Value Asset, ending of period       889    
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Contingent Consideration | Acquisitions            
Assets and liabilities measured at fair value            
Fair Value Liability, beginning of period   11,290 11,290 11,082   11,082
Purchases, Issuances and Settlements     (7,024)   $ 10,833  
Realized Liability Gains/(Losses)     (4,266) 208 249  
Fair Value Liability, ending of period       11,290 11,082  
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Convertible Note | Acquisitions            
Assets and liabilities measured at fair value            
Fair Value Asset, beginning of period   $ 889 889 5,006 5,006 $ 5,006
Purchases, Issuances and Settlements     $ (889)   0  
Realized Liability Gains/(Losses)       (4,117) 0  
Fair Value Asset, ending of period       $ 889 $ 5,006